Biomitra Pharma Private Limited
About Biomitra Pharma Private Limited
Data last updated:
Biomitra Pharma Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 06 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999HR2017PTC067351. Its GSTIN is 20AAHCB1790J1ZU (Jharkhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹50,000. It is led by directors Shiv Kumar Ray and Nayeem Ur Raza.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Shop No.C – 126 GF Sushant Shoping Arcade Sushant Lok – 1 Gurgaon, Haryana, India – 122209.
As per the financials filed for FY 2022, the company reported a revenue of ₹8 Lakh, a decline of 50% compared to the previous year. For the same year it recorded a net profit of ₹19,200 (net margin 2.4%) and EBITDA of ₹27,890 (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 116% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Biomitra Pharma Private Limited's registered office is in Gurgaon, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No.C – 126 GF Sushant Shoping Arcade Sushant Lok – 1 Gurgaon, Haryana, India – 122209
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Biomitra Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Biomitra Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Biomitra Pharma Private Limited, buy the company report.
Financials of Biomitra Pharma Private Limited
FY 2022 filings availableBiomitra Pharma Private Limited reported revenue of ₹8 Lakh (down 50% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue fell 50% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 116%. EBITDA fell 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹27,890 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19,200 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biomitra Pharma Private Limited, buy the company report.
Board of directors of Biomitra Pharma Private Limited
Biomitra Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shiv Kumar Ray | Director | 04 Jan 2021 | 5 Years 9 Months | Current |
| Nayeem Ur Raza Also directs: Nextext Services Private Limited | Director | 04 Jan 2021 | 5 Years 9 Months | Current |
Peer comparison
Biomitra Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arykem Pharmaceuticals Private Limited | ₹8.01 Lakh (FY 2025) | -12.0% | Sarojini Nagar, Uttar Pradesh, India | |||
| Biomitra Pharma Private Limitedthis company | ₹8 Lakh (FY 2022) | ₹19,200 | 2.4% | -50.0% | Gurgaon, Haryana, India | |
| Greenbuzz Energy Private Limited | ₹8 Lakh (FY 2023) | -50.0% | Bangalore, Karnataka, India | |||
| Easyfin Credicare Private Limited | ₹8 Lakh (FY 2025) | 39.0% | Kolkata, West Bengal, India | |||
| Model Dealtrade Private Limited | ₹8 Lakh (FY 2021) | Kolkata, West Bengal, India | ||||
| Magsys Quantech Private Limited | ₹8 Lakh (FY 2023) | 31646.0% | Patna, Bihar, India | |||
| Ads Realtors and Developers Private Limited | ₹8 Lakh (FY 2021) | 0.0% | Hyderabad, Telangana, India | |||
| Hi-Tech Generators and Engineers Limited | ₹8 Lakh (FY 2020) | -39.0% | Delhi, India | |||
| Nahata Industries Private Limited | ₹8 Lakh (FY 2025) | 6.0% | Kolkata, West Bengal, India | |||
| Adamas Dairy Equipments Private Limited | ₹8 Lakh (FY 2025) | -36.0% | New Delhi, Delhi, India | |||
| Madaksh Consumer Private Limited | ₹8 Lakh (FY 2024) | 3196.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Biomitra Pharma Private Limited, buy the company report.
Auditor
Biomitra Pharma Private Limited is audited by MUKESH DHINGRA for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MUKESH DHINGRA | FY 2017 | 538938 |
Shareholding
The shareholding of Biomitra Pharma Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Biomitra Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biomitra Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biomitra Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biomitra Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AAHCB1790J1ZU | Jharkhand | Active | 13 Jul 2021 |
To see the full GST registrations and return filing status of Biomitra Pharma Private Limited, buy the company report.
Recent activity
Biomitra Pharma Private Limited has 6 board changes on record since 2021: 2 appointments and 4 cessations. The latest: Alok Kumar Jayaswal ceased to be Director on 14 Jun 2022.
Frequently asked questions
Biomitra Pharma is an active private limited company based in Gurgaon, Haryana, India. The company works in wholesale, within the trading industry. It was incorporated on 06 February 2017 (9+ years old) and is registered under CIN U74999HR2017PTC067351.
Biomitra Pharma has 2 current directors:
- Shiv Kumar Ray - Director
- Nayeem Ur Raza - Director
The latest financial statements of Biomitra Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Biomitra Pharma is 20AAHCB1790J1ZU, registered in Jharkhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Biomitra Pharma is U74999HR2017PTC067351. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biomitra Pharma was incorporated on 06 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Biomitra Pharma by revenue are Arykem Pharmaceuticals Private Limited, Greenbuzz Energy Private Limited, Easyfin Credicare Private Limited, Model Dealtrade Private Limited, Magsys Quantech Private Limited and 5 more, all in the same principal business activity (retail trading).
Alok Kumar Jayaswal ceased to be Director on 14 Jun 2022. Kumar Gaurav Goswami ceased to be Director on 04 Jan 2021. Navneet Verma ceased to be Director on 04 Jan 2021. Biomitra Pharma has 6 board changes on record in total.
The registered office of Biomitra Pharma is at Shop No.C – 126 GF Sushant Shoping Arcade Sushant Lok – 1 Gurgaon, Haryana, India – 122209.
Biomitra Pharma operates in the trading industry, in the wholesale segment.
The compliance status of Biomitra Pharma is compliant as of 29 July 2026. The company is actively filing with the Registrar of Companies.